Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui, Toshihiro
Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. [electronic resource] - Annals of the rheumatic diseases Sep 2007 - 1221-6 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0003-4967
10.1136/ard.2006.063834 doi
Aged
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--blood
Biomarkers--blood
Blood Sedimentation
C-Reactive Protein--analysis
Cohort Studies
Cross-Sectional Studies
Disease Progression
Female
Glucocorticoids--therapeutic use
Humans
Japan
Male
Middle Aged
Severity of Illness Index
Treatment Outcome
Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. [electronic resource] - Annals of the rheumatic diseases Sep 2007 - 1221-6 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0003-4967
10.1136/ard.2006.063834 doi
Aged
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--blood
Biomarkers--blood
Blood Sedimentation
C-Reactive Protein--analysis
Cohort Studies
Cross-Sectional Studies
Disease Progression
Female
Glucocorticoids--therapeutic use
Humans
Japan
Male
Middle Aged
Severity of Illness Index
Treatment Outcome